Uncategorized
NovaBay grows revenue, gross profit with Avenova sales
NovaBay Pharmaceuticals reported increases in product revenue and gross profit in the first quarter 2015 due to the commercialization of Avenova, according to a press release.Product revenue increased to $492,000 from $188,000 in the first quarter 2014, and gross profit rose to $344,000 from $58,000 in the first quarter of the previous year.